Journal of Clinical Images and Medical Case Reports

ISSN 2766-7820
Case Report - Open Access, Volume 3

Emergence of extended-spectrum beta-lactamase CTX-M-27 in Shigella sonnei clinical isolate from croatia

Branka Bedenić1,2; Ines Jajić3; Ana Benčić3; Ivan Barišić4; Josefa Luxner5; Nataša Beader1,2*

1School of Medicine, University of Zagreb, Croatia.

2University Hospital Center Zagreb, Croatia.

3Sestre Milosrdnice University Hospital, Zagreb, Croatia.

4AIT, Austrian Institute for Technology, Vienna, Austria.

5D&R Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Neue Stiftingtalstraße 6, 8010 Graz, Austria.

*Corresponding Author : Prof. Nataša Beader
University of Zagreb School of Medicine, Department of Clinical and Molecular Microbiology, University Hospital Center Zagreb, Kišpatićeva 12, 10000 Zagreb, Croatia. Tel: +385-23-67-304, Fax: +385-23-67-393;
Email: [email protected]

Received : Jul 21, 2022

Accepted : Aug 09, 2022

Published : Aug 16, 2022

Archived :

Copyright : © Beader N (2022).


The patient developed bacillary dysentery with frequent stools mixed with blood and mucus and was hospitalized in Sestre Milosrdnice Hospital in Zagreb, Croatia. Shigella sonnei was isolated from the stool specimen. The antibiotic susceptibility testing was performed by disk-diffusion and broth microdilution method. Double disk synergy test and combined disk test with clavulanic acid were done to determine the production of an Extended-Spectrum Beta-Lactamase (ESBL). The transferability of cefotaxime resistance was done by broth mating method. PCR was applied to detect genes encoding ESBLs. Whole genome sequencing was performed to analyse the whole resistome of the strain.

The strain exhibited resistance to amoxicillin, cephalexin, cefuroxime, azithromycin, tetracycline, cefotaxime, ceftriaxone, and ciprofloxacin but remained susceptible to ceftazidime, cefepime, amoxicillin/clavulanic acid, piperacillin/tazobactam, imipenem, meropenem and gentamicin. Phenotypic tests confirmed production of an ESBL. PCR identified blaCTX-M gene belonging to the cluster 1. WGS demonstrated a variety of aminoglycoside, β-lactam macrolide sulphonamide (trimethoprim and tetracycline resistance determinants. Four different plasmids were found: IncFIB, IncFII, IncI1 and Inc Col. The isolate was found to belong to the widespread ST152 which is dominant in Europe and North America and usually associate with MSM population. To our best knowledge, this is the first report of an ESBL in Shigella spp. from Croatia. This report emphasizes the ability of S. sonnei belonging to the widespread ST 152 to accumulate various resistance determinants.

Keywords: Shigella sonnei; Antibacterial resistance; Extended-Spectrum Beta-Lactamase (ESBL); CTX-M beta-lactamase.

Citation: Bedenić B, Jajić I, Benčić A, Barišić I, Beader N, et al. Emergence of extended-spectrum beta-lactamase CTX-M-27 in Shigella sonnei clinical isolate from Croatia. J Clin Images Med Case Rep. 2022; 3(8): 2000.


Recently, it was observed that shigellae can acquire a wide variety of different resistance traits including genes encoding broad and extended-spectrum β-lactamases and carbapenemases [1]. Resistance to fluoroquinolones is usually due to Plasmid-Mediated Fluoroquinolone-Resistance Region (PMQRs), including qnrA, qnrB, qnrC, qnrD and qnrS genes [2].

Case report

The patient was a 30 year old male, who inhaled sewage during work due to the rupture of the sewage pipeline. He developed bacillary dysentery with frequent stools mixed with blood and mucus and was hospitalized in Sestre Milosrdnice Hospital in Zagreb, Croatia. He was released after 1 day without antibiotic therapy.

The antimicrobial susceptibility of the strain 27789 to amoxicillin alone and combined with clavulanate, expanded- spectrum cephalosporins (ceftazidime, cefotaxime, ceftriaxone), cefepime, imipenem, meropenem, ertapenem, gentamicin, ciprofloxacin, tetracycline and azithromycin was determined by broth microdilution method according to Clinical & Laboratory Standards Institute standards [3]. Escherichia coli ATCC 25922 and Klebsiella pneumonia ATCC 700603 were used as quality control strains for Minimum Inhibitory Concentration (MIC) determination. The susceptibility Totrimethoprim/Sulfamethoxazole (SXT/TMP) and chloramphenicol was determined by disk-diffusion test. MDR was defined as resistance to >3 antimicrobial drug classes and clinical resistance as resistance to >1 of the major antimicrobial drug classes (penicillins, cephalosporins, folate-pathway inhibitors, fluoroquinolones, tetracyclines and macrolides [4].

The Double Disk Synergy Test (DDST) [5] was carried out in the frames of routine laboratory analysis of the isolates. ESBL production was confirmed by CLSI combined disk test using disks with expanded-spectrum cephalosporins (ceftazidime, cefotaxime, ceftriaxone) or ESC alone and with addition of clavulanic acid [3]. Plasmid-Mediated Ampc Β-Lactamases (p-AmpC) were detected by combined disk test using cephalosporin disks with 3-Aminophenylboronic Acid (PBA) [6]. To confirm cefotaxime hydrolysis a modified method described for carbapenem inactivation was done [7]. The transferability of cefotaxime resistance was determined by conjugation (broth mating method) at 35°C employing E. coli J 65 recipient strain resistant to sodium-azide [8]. The transconjugants were selected on Mac Conkey agar containing either ampicillin (0.5 mg/L) or ciprofloxacin (0.5 mg/L) and sodium azide (100 mg/L).

The genes conferring resistance to β-lactam antibiotics including (blaSHV, blaTEM, blaCTX-M, blaOXA-9, blaOXA-1 and blaPER-1) [9-12], p-AmpC β-lactamases [13], and fluoroquinolone resistance genes qnrA, qnrB, qnrS [14] were determined by PCR using protocols and conditions as described previously.The CTX-M β-lactamase cluster was detected with multiplex PCR including five primer pairs: CTX-M-1, CTX-M-2, CTX-M-8, CTX-M-9, and CTX-M-25 [15]. Amplicons were visualised after electrophoresis in a 1% agarose gel by staining it with ethidium bromide. The genetic context of blaCTX-M genes was determined by PCR mapping with forward primer for insertion sequences ISEcp1 and IS26 combined with primer MA-3 (universal reverse primer for blaCTX-M genes) [16].

Plasmids were extracted from ampicillin resistant donor strains and their respective transconjugants with Qiagen plasmid mini kit according to the manufacturer’s instructions (Hilden, Germany). After staining with ethidium bromide, the DNA was visualised by ultraviolet light. PCR-Based Replicon Typing (PBRT) was applied to determine the plasmid content of the tested strains [17,18]. WGS was done using the Ion Torrent PGM platform (Life Technologies, Carlsbad, USA) according to the manufacturer’s instructions [19].

The isolate was genotyped by MLST according to the protocol of University of Warwick/EnteroBase website:

The strain exhibited resistance to amoxicillin, cephalexin, cefuroxime, azithromycin, tetracycline, cefotaxime, ceftriaxone, and ciprofloxacin with MIC values of ≥128, ≥128, ≥128, ≥128, ≥128, 32, 8 and 8 mg/L, respectively, but remained susceptible to were ceftazidime, cefepime, amoxicillin/clavulanic acid, piperacillin/tazobactam, imipenem, meropenem and gentamicin with MIC of 8, 0.5, 1, 0.25, 0.06, 0.06, and 1 mg/L. Cotrimoxazole and cefoxitin tested resistant and susceptible in disk-diffusion test with the inhibition zones of 6 and 25 mm, respectively. DDST and inhibitor based test with clavulanic acid tested positive, indicating production of an ESBL. Inhibitor based test with PBA exhibited negative result. PCR identified blaCTX-M gene belonging to the cluster 1, but PCR for insertion sequences displayed negative result. WGS demonstrated a variety of aminoglycoside (aadA, aph(6), aph(3), β-lactam (blaCTX-M-27), macrolide (Erm (B,) Mph (A)), sulphonamide (sul 1), trimethoprim (dfrA17,dfrA)and tetracycline (tet A) and a variety of virulence determinants (Table 1). Four different plasmids were found: IncFIB, IncFII, IncI1 and IncCol. The gene sequences were deposited in the Gene bank with accession number JAMKCB000000000.


The isolate was found to belong to the widespread ST152 which is dominant in Europe and North America and usually associate with MSM population [20]. ESBLs were reported in Shigella spp. in developing countries almost two decades ago [21], but they are still rare in Europe [22]. The majority of other reports identified CTX-M-3 and CTX-M-15 allelic variants whereas our study found CTX-M-27. This allelic variant was recently described in S. sonnei in UK and Australia [23,24]. Plasmid-mediated resistance determinants to fluoroquinolones were not found and thus it is very likely that ciprofloxacin resistance was associated with mutations of gyrA and parC genes. IncFIB and IncFII plasmids were previously identified in CTX-M producing E. coli from Croatia [25] where as IncI1 was carried by CTX-M positive E. coli strains from chicken [26].

Table 1: The course of endoscopic treatments.
Isolate AG β-lactam FQ ML SUL TET TMP Plasmid inc groups
Shigellasonnei27789 aadA5


blaCTX-M-27 aac(6')Ib-cr



Sul1 tetA dfrA17, dfrA1 Col, IncFIB, IncFII IncI1
Virulence traits

invasion protein


plasmid encoded enterotoxin

complement resistance

transcriptional activator

iron transport protein

IgA protease


Abbreviations: FQ: Fluoroquinolones; ML: Macrolides; SUL: Sulphonamides; TET: Tetracyclines; TMP: Trimethoprim.


To our best knowledge, this is the first report of an ESBL in Shigella spp. from Croatia. Intestinal carriage of ESBL positive coliform bacteria is increasing in the outpatient setting which leads to the conclusion that blaESBL gene may have been transferred from K.pneumoniae or E. coli by in vivo conjugation. This report emphasizes the ability of S. sonnei belonging to the widespread ST 152 to accumulate various resistance determinants.


  1. Torraca V, Holt K, Mostowy S. Shigellasonnei. Trends Microbiol. 2020; 28: 696-697.
  2. Ranjbar R, Farahani A. Shigella. Antibiotic resistance mechanisms and new horizons for treatment. Infect Drug Resistance. 2019; 12: 3137-3167.
  3. CLSI. Performance Standards for Antimicrobial Susceptibility Testing, document M100, 30th edition. Wayne, PA: Clinical and Laboratory Standards Institute; 2020.
  4. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. ClinMicrobiol Infect. 2012; 18: 268-281. Available from: http://doi: 10.1111/ /j.1469-0691.2011.03570.x
  5. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infect Dis. 1998; 10: 867-878. Available from: http://doi: 10.1093/clinids/10.4.867.
  6. Coudron PE. Inhibitor-based methods for detection of plasmid-mediated AmpC β-lactamases in Klebsiellaspp., Escherichia coli and Proteus mirabilis. J Clin Microbiol. 2005; 43: 416-417. Available from: http://doi: 10.1128/JCM. 43.8.4163-4167.2005.
  7. van der Zwaluw K, de Haan A, Pluister GN, Bootsma HJ, de Neeling AJ, et al. The Carbapenem-Inacitvation Method (CIM) a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in Gram-negative rods. Plos One. 2015; 10: e0123690. Available from: http://doi: 10.1371//journal.pone.0123690
  8. Elwell LP, Falkow S. The characterization of R plasmids and the detection of plasmid-specified genes. In: Lorian V (ed) Antibiotics in Laboratory Medicine. 2ndedn. Baltimore MD: Williams and Wilkins. 1986; 683-721.
  9. Arlet G, Brami G, Decre D, Flippo A, Gaillot O, et al. Molecular characterization by PCR restriction fragment polymorphism of TEM β-lactamases. FEMS Microbiol Lett. 1995; 134: 203-208. Available from: http://doi: 10.1111/j.1574-6968.1995.tb07938.x.
  10. Nüesch Inderbinen MT, Hächler H, Kayser FH. Detection of genes coding for extended-spectrum SHV β-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis. 1996; 15: 398-402. Available from: http://doi: 10.1007/ BF01690097.
  11. Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother. 2004; 54: 735-743. Available from: http://doi: 10.1093/ jac/dkh424
  12. Pagani L, Mantengoli E, Migliavacca R, Nucleo E, Pollini S, et al. Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing PER-1 extended-spectrum β-lactamase in Northern Italy. J Clin Microbiol. 2004; 42: 2523-2529. Available from: http://doi: 10.1128/JCM. 42.6.2523-2529.2004.
  13. Perez Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J ClinMicrobiol. 2002; 40: 2153-2162. Available from: http://doi: 10.1128/jcm.40.6.2153-2162.2002.
  14. Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis. 2006; 6: 629-640. Available from: http://doi: 10.1016/S1473-3099(06) 70599-0.
  15. Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases. J Antimicrob Chemother. 2006; 57: 154-155. Available from: http://doi: 10.1093/jac/dki412.
  16. Saladin M, Cao VT, Lambert T, Donay JL, Herrmann JL, et al. Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett. 2002; 209: 161–168. Available from: http://doi: 10.1111/j.1574-6968.2002.tb11126.x.
  17. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, et al. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005; 63: 219-28. Available from: http://doi: 10.1016/j.mimet2005.03.018.
  18. Carattoli A, Sieffert S, Schwendener S, Perreten V, Endimiani A, et al. Differentiation of IncL and IncM plasmids associated with the spread of clinically relevant antimicrobial resistance. Plos one. 2015; 10: e0123063.
  19. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012; 67: 2640-2644. Available from: http:// doi: 10.1093/jac/dks261
  20. Eikmeier D, Talley P, Bowen A, Leano F, Dobbins G, et al. Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012-2015. Emerg Infect Dis. 2020; 26: 667-674.
  21. Rahman M, Shoma S, Rashid H, Siddique AK, Nair GB, et al. Extended-spectrum beta-lactamase-mediated third-generation cephalosporin resistance in Shigella isolates in Bangladesh. J Antimicrob Chemother 2004; 54: 846-847.
  22. Campos Madueno EI, Bernasconi OJ, Moser AI, Keller PM, Luzzaro F, et al. Rapid Increase of CTX-M-Producing Shigellasonnei Isolates in Switzerland Due to Spread of Common Plasmids and International Clones. Antimicrob Agents Chemother. 2020; 64: e01057-20. Available from: http://doi: 10.1128/AAC.01057-20.
  23. Locke RK, Greig DR, Jenkins C, Dallman TJ, Cowley LA, et al. Acquisition and loss of CTX-M plasmids in Shigella species associated with MSM transmission in the UK. Microb Genom. 2021; 7: 000644. Available from: http://doi: 10.1099/mgen.0.000644.
  24. Ingle DJ, Andersson P, Valcanis M, Barnden J, da Silva AG, et al. Prolonged Outbreak of Multidrug-Resistant Shigellasonnei Harboring blaCTX-M-27 in Victoria, Australia. Antimicrob Agents Chemother. 2020; 64: e01518-e01520. Available from: http://doi: 10.1128/AAC.01518-20.
  25. Literacka E, Bedenic B, Baraniak A, Fiett J, Tonkic M, et al. BlaCTX-M genes in Escherichia coli from Croatian hospitals are located in new (blaCTX-M-3) and widely spread (blaCTX-M-3a, blaCTX-M-15) genetic structures. Antimicrob Agents Chemother. 2009; 53: 1630-1635.
  26. Fetahagić M, Ibrahimagić A, Uzunović S, Beader N, Elveđi Gašparović V, et al. Detection and characterisation of extended-spectrum and plasmid-mediated AmpC β-lactamase produced by Escherichia coli isolates found at poultry farms in Bosnia and Herzegovina. Arh Hig Rada Toksikol. 2021; 72: 305-314. Available from: http://doi: 10.2478/aiht-2021-72-3560.